• Publications
  • Influence
Rituximab for patients with refractory mucous membrane pemphigoid.
BACKGROUND Mucous membrane pemphigoid (MMP) still represents a potentially life- and sight-threatening disease. In a subset of patients with severe MMP, conventional immunosuppressants areExpand
  • 91
  • 5
  • PDF
Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation
Fanconi anemia (FA) is a chromosomal instability disorder with a very high risk of developing head and neck squamous cell carcinoma (HNSCC), most notably after hematopoietic stem cell transplantationExpand
  • 84
  • 5
Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita.
Epidermolysis bullosa acquisita (EBA) is a rare autoimmune bullous disease (AIBD). However, higher EBA incidence and predisposing genetic factor(s) involving an HLA haplotype have been suspected inExpand
  • 64
  • 4
A Prospective Study of Upper Aerodigestive Tract Manifestations of Mucous Membrane Pemphigoid
Abstract: We conducted a prospective study between 1995 and 2002 to investigate nose and throat (NT) manifestations of mucous membrane pemphigoid (MMP). One hundred ten consecutive patients withExpand
  • 63
  • 2
Pemphigoïde cicatricielle : traitement par mycophénolate mofétil
Resume Introduction La gravite de la pemphigoide cicatricielle (PC) est variable. Le traitement des formes peu ou moyennement severes repose sur la dapsone. Dans les formes graves, les bolus deExpand
  • 20
  • 1
Oesophageal involvement in 26 consecutive patients with mucous membrane pemphigoid
Oesophageal involvement of mucous membrane pemphigoid (MMP) has not yet been thoroughly described.
  • 13
  • 1
[Cicatricial pemphigoid: treatment with mycophenolate mofetil].
BACKGROUND The severity of cicatricial pemphigoid (CP) varies. First-intent treatment of mild or moderate cases is dapsone. In life or sight-threatening cases, intravenous cyclophosphamide pulses areExpand
  • 10
  • 1
[Topical tretinoin in the treatment of lichen planus and leukoplakia of the mouth mucosa. A clinical evaluation].
A randomized study was conducted to evaluate the effect of tretinoin and patient tolerance to treatment with topical applications in series of 20 cases of smoking-related or traumatic oral keratosesExpand
  • 43
Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid
Background  Mucous membrane pemphigoid (MMP) still represents a potentially life‐ and sight‐threatening disease. Immunosuppressants, such as cyclophosphamide (CYC), are indicated for patients withExpand
  • 28
[Topical tretinoin in the treatment of lichen planus and leukoplakia of the oral mucosa. A biochemical evaluation of the keratinization].
In earlier work, we demonstrated that 0.1 p. 100 topical tretinoin is clinically effective and well tolerated compared with placebo for the treatment of oral leukoplakia and oral keratosic orExpand
  • 6